Philadelphia-Like Acute Lymphoblastic Leukemia in Adults.

about

B lymphoblastic leukemia/lymphoma: new insights into genetics, molecular aberrations, subclassification and targeted therapy.Treatment of Older Patients with Acute Lymphoblastic Leukaemia.

P2860

Q42371687-330615AB-DFE2-4C6E-B6AD-05B2951CBA85 Q47774455-B26B8E44-60DF-4CE5-B64A-0F5CB54399CA

P2860

Philadelphia-Like Acute Lymphoblastic Leukemia in Adults.

Item

http://www.wikidata.org/entity/Q39210250

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Philadelphia-Like Acute Lymphoblastic Leukemia in Adults.

@en

Philadelphia-Like Acute Lymphoblastic Leukemia in Adults.

@nl

type

Item

label

Philadelphia-Like Acute Lymphoblastic Leukemia in Adults.

@en

Philadelphia-Like Acute Lymphoblastic Leukemia in Adults.

@nl

prefLabel

Philadelphia-Like Acute Lymphoblastic Leukemia in Adults.

@en

Philadelphia-Like Acute Lymphoblastic Leukemia in Adults.

@nl

P1476

Philadelphia-Like Acute Lymphoblastic Leukemia in Adults.

@en

P2093

Nicola Gökbuget

http://www.w3.org/2001/XMLSchema#string

Tobias Herold

http://www.w3.org/2001/XMLSchema#string

P2860

Acute lymphoblastic leukaemia

A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study

Redefining ALL classification: toward detecting high-risk ALL and implementing precision medicine

Tyrosine kinase inhibitor therapy induces remission in a patient with refractory EBF1-PDGFRB-positive acute lymphoblastic leukemia.

RNA-seq identifies clinically relevant fusion genes in leukemia including a novel MEF2D/CSF1R fusion responsive to imatinib.

Sensitivity of SNX2-ABL1 toward tyrosine kinase inhibitors distinct from that of BCR-ABL1.

Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia

Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study.

Outcomes of children with BCR-ABL1–like acute lymphoblastic leukemia treated with risk-directed therapy based on the levels of minimal residual disease.

Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia.

P2888

s11912-017-0589-2

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11912-017-0589-2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Nicola Gökbuget

P577

2017-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28361222

http://www.w3.org/2001/XMLSchema#string

Philadelphia-Like Acute Lymphoblastic Leukemia in Adults.

about

P2860

P2860

Philadelphia-Like Acute Lymphoblastic Leukemia in Adults.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698